Neuromelanin MRI in a family with mitochondrial parkinsonism harboring a Y955C mutation in POLG1

Parkinsonism and Related Disorders

Volumn 19, Issue 9, 2013, Pages 821-824

  Mukai, Masako ^a   Sugaya, Keizo ^a   Yabe, Ichiro ^b   Goto, Yu ichi ^c   Yokochi, Fusako ^a   Miyamoto, Kazuhito ^a   Cai, Huaying ^b   Sasaki, Hidenao ^b   Matsubara, Shiro ^a  

^a TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

Mitochondrial DNA; Neuromelanin imaging; Parkinsonism; POLG1; Progressive external ophthalmoplegia

Indexed keywords

MITOCHONDRIAL DNA; NEUROMELANIN;

AGED; ARTICLE; CASE REPORT; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IDIOPATHIC PARKINSON DISEASE; JAPANESE; LOCUS CERULEUS; MUSCLE BIOPSY; NERVE CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARKINSON DISEASE; PARKINSONISM; POLG1 GENE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

MITOCHONDRIAL DNA; NEUROMELANIN IMAGING; PARKINSONISM; POLG1; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;

AGED; DNA, MITOCHONDRIAL; DNA-DIRECTED DNA POLYMERASE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MELANINS; MITOCHONDRIA; MUTATION; OPHTHALMOPLEGIA, CHRONIC PROGRESSIVE EXTERNAL; PARKINSONIAN DISORDERS; PEDIGREE;

EID: 84880815779     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2013.04.011     Document Type: Article

References (12)

1. Bender A., Krishnan K.J., Morris C.M., Taylor G.A., Reeve A.K., Perry R.H., et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 2006, 38:515-517.
2. Luoma P., Melberg A., Rinne J.O., Kaukonen J.A., Nupponen N.N., Chalmers R.M., et al. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 2004, 364:875-882.
3. Sato K., Yabe I., Yaguchi H., Nakano F., Kunieda Y., Saitoh S., et al. Genetic analysis of two Japanese families with progressive external ophthalmoplegia and parkinsonism. JNeurol 2011, 258:1327-1332.
4. Hattori N., Kitada T., Matsumine H., Asakawa S., Yamamura Y., Yoshino H., et al. Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals. Ann Neurol 1998, 44:935-941.
5. Komaki H., Fukazawa T., Houzen H., Yoshida K., Nonaka I., Goto Y. Anovel D104G mutation in the adenine nucleotide translocator 1 gene in autosomal dominant progressive external ophthalmoplegia patients with mitochondrial DNA with multiple deletions. Ann Neurol 2002, 51:645-648.
6. Schwarz S.T., Rittman T., Gontu V., Morgan P.S., Bajaj N., Auer D.P. T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease. Mov Disord 2011, 26:1633-1638.
7. Ohtsuka C., Sasaki M., Konno K., Koide M., Kato K., Takahashi J., et al. Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging. Neurosci Lett 2013, 541:93-98.
8. Shibata E., Sasaki M., Tohyama K., Kanbara Y., Otsuka K., Ehara S., et al. Age-related changes in locus ceruleus on neuromelanin magnetic resonance imaging at 3Tesla. Magn Reson Med Sci 2006, 5:197-200.
9. Poulopoulos M., Levy O.A., Alcalay R.N. The neuropathology of genetic Parkinson's disease. Mov Disord 2012, 27:831-842.
10. Ponamarev M.V., Longley M.J., Nguyen D., Kunkel T.A., Copeland W.C. Active site mutation in DNA polymerase gamma associated with progressive external ophthalmoplegia causes error-prone DNA synthesis. JBiol Chem 2002, 277:15225-15228.
11. Elstner M., Muller S.K., Leidolt L., Laub C., Krieg L., Schlaudraff F., et al. Neuromelanin, neurotransmitter status and brainstem location determine the differential vulnerability of catecholaminergic neurons to mitochondrial DNA deletions. Mol Brain 2011, 21(4):43.
12. Jellinger K.A. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts. Mov Disord 2012, 27:8-30.